The high cost of prescription drugs in America has again moved back into the political spotlight, with President Trump ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

The state accuses CVS of breaking the law by owning pharmacies and a pharmacy benefit manager, known as a PBM.

Louisiana’s attorney general accuses CVS and Caremark of using patient data to push legislation and inflating drug prices, ...

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...

Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug ...

CVS launched a massive grassroots lobbying campaign, including text messages to customers urging them to reach out to their ...

CVS Health and its subsidiaries have experienced a turbulent week in the courts. | Not long after the state of Louisiana sued ...

CVS Caremark has been ordered to pay $95 million after a federal judge found the pharmacy benefit manager improperly inflated Medicare Part D drug prices by failing to report required pharmacy ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

The outcome could affect everyone in Louisiana who buys prescription drugs, especially those who purchase specialty drugs that treat such maladies as diabetes, neuropathy and inattention or ...

The lawsuits were filed after CVS sent text messages to its customers urging them to tell their legislators to oppose a ...